{"transactions":[{"id":4630074,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-10-05T20:18:35.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":230.33,"value":1381980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":345875,"source":{"system":"sec-edgar","filing":"0001193210-26-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000028/edgardoc.xml","form_type":"4"}},{"id":942,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":250.13,"value":1500780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":351875,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":941,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-08-31","kind":"tax_withholding","planned":true,"acquired":false,"shares":1209,"price":241.3899,"value":291840.3891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":357875,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":940,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-02T21:03:36.000Z","date":"2026-08-31","kind":"tax_withholding","planned":true,"acquired":false,"shares":10,"price":244.064,"value":2440.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the November 3, 2025 disposition of 3,193 shares for the withholding of restricted stock units by the Issuer to satisfy FICA taxes arising from the Reporting Person being retirement eligible which was previously inadvertently not reported; not an open market transaction."}],"balance_after":359084,"source":{"system":"sec-edgar","filing":"0001193210-26-000025","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000025/edgardoc.xml","form_type":"4"}},{"id":692941,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-07T21:31:54.000Z","date":"2026-08-05","kind":"grant","planned":false,"acquired":true,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 23, 2027."}],"balance_after":362287,"source":{"system":"sec-edgar","filing":"0001193210-26-000020","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000020/edgardoc.xml","form_type":"4"}},{"id":695444,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-08-05T20:33:08.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":252.98,"value":1517880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":360682,"source":{"system":"sec-edgar","filing":"0001193210-26-000018","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000018/edgardoc.xml","form_type":"4"}},{"id":714859,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-06T22:23:03.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":240.47,"value":1442820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":366682,"source":{"system":"sec-edgar","filing":"0001193210-26-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000016/edgardoc.xml","form_type":"4"}},{"id":751307,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-06-03T21:09:45.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":235.12,"value":1410720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":372682,"source":{"system":"sec-edgar","filing":"0001193210-26-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000013/edgardoc.xml","form_type":"4"}},{"id":791457,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-05-05T20:27:21.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":6000,"price":203.33,"value":1219980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":378682,"source":{"system":"sec-edgar","filing":"0001193210-26-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000011/edgardoc.xml","form_type":"4"}},{"id":815974,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":24,"price":191.7447,"value":4601.8728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."}],"balance_after":384682,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":815973,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":2292,"price":190.9383,"value":437630.5836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $190.6051 to $190.5982. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":384706,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":815972,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-04-03T21:09:49.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":3684,"price":190.222,"value":700777.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $189.60 to $190.5603. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":386998,"source":{"system":"sec-edgar","filing":"0001193210-26-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000009/edgardoc.xml","form_type":"4"}},{"id":853302,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:31:30.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":15114,"price":188.69,"value":2851860.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":390682,"source":{"system":"sec-edgar","filing":"0001193210-26-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000007/edgardoc.xml","form_type":"4"}},{"id":861073,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":233,"price":187.8444,"value":43767.7452,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $187.7783 to $188.1678 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":405796,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":861072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":2608,"price":186.734,"value":487002.272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $186.500 to $187.4693. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":406029,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":861071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:24:46.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":3159,"price":186.0853,"value":587843.4627,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $185.500 to $186.4207. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":408637,"source":{"system":"sec-edgar","filing":"0001193210-26-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000005/edgardoc.xml","form_type":"4"}},{"id":934100,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-22T00:16:13.000Z","date":"2026-01-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":17453,"price":171.16,"value":2987255.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations."}],"balance_after":411796,"source":{"system":"sec-edgar","filing":"0001193210-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000002/edgardoc.xml","form_type":"4"}},{"id":934099,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-22T00:16:13.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":35917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance\nattained was certified."}],"balance_after":429249,"source":{"system":"sec-edgar","filing":"0001193210-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321026000002/edgardoc.xml","form_type":"4"}},{"id":984959,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":76689,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":123.36,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":76689},"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984958,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":811,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":123.36,"expiration_date":"2026-02-24","underlying":"Ordinary Shares","underlying_shares":811},"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984957,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":38126,"price":177.272,"value":6758672.272,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $176.70 to $177.69. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":393332,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984956,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":507,"price":179.7923,"value":91154.6961,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $179.73 to $179.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":431458,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984955,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":8380,"price":179.2295,"value":1501943.21,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $178.72 to $179.705. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":431965,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984954,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":30487,"price":178.0617,"value":5428567.0479,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $177.70 to $178.685. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":440345,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984953,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":811,"price":123.36,"value":100044.96,"ownership":{"direct":true},"balance_after":470832,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":984952,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-12-01T23:14:23.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":76689,"price":123.36,"value":9460355.04,"ownership":{"direct":true},"balance_after":470021,"source":{"system":"sec-edgar","filing":"0001193210-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000011/edgardoc.xml","form_type":"4"}},{"id":992390,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-21T01:03:29.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":2506,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026."}],"balance_after":393332,"source":{"system":"sec-edgar","filing":"0001193210-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000009/edgardoc.xml","form_type":"4"}},{"id":992389,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-21T01:03:29.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":717,"price":182.6009,"value":130924.8453,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $181.59 to $182.77. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":390826,"source":{"system":"sec-edgar","filing":"0001193210-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000009/edgardoc.xml","form_type":"4"}},{"id":992388,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-21T01:03:29.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":5517,"price":181.8146,"value":1003071.1482,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $181.41 to $182.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":391543,"source":{"system":"sec-edgar","filing":"0001193210-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000009/edgardoc.xml","form_type":"4"}},{"id":992387,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-21T01:03:29.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":8382,"price":180.8794,"value":1516131.1308,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $180.4028 to $181.385. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":397060,"source":{"system":"sec-edgar","filing":"0001193210-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000009/edgardoc.xml","form_type":"4"}},{"id":992386,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-11-21T01:03:29.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":3384,"price":180.0859,"value":609410.6856,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $179.4013 to $180.38. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":405442,"source":{"system":"sec-edgar","filing":"0001193210-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000009/edgardoc.xml","form_type":"4"}},{"id":1024301,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-04T01:27:59.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":140,"value":490000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":408826,"source":{"system":"sec-edgar","filing":"0001193210-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000007/edgardoc.xml","form_type":"4"}},{"id":1024300,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-10-04T01:27:59.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":131.78,"value":263560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":412326,"source":{"system":"sec-edgar","filing":"0001193210-25-000007","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000007/edgardoc.xml","form_type":"4"}},{"id":1037456,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-17T21:21:47.000Z","date":"2025-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":15647,"price":126.16,"value":1974025.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":414326,"source":{"system":"sec-edgar","filing":"0001193210-25-000005","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000119321025000005/edgardoc.xml","form_type":"4"}},{"id":1047696,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-04T21:48:16.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":130,"value":390000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":429973,"source":{"system":"sec-edgar","filing":"0001765581-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000098/edgardoc.xml","form_type":"4"}},{"id":1047695,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-09-04T21:48:16.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":127.23,"value":381690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":432973,"source":{"system":"sec-edgar","filing":"0001765581-25-000098","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000098/edgardoc.xml","form_type":"4"}},{"id":1074281,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-08-05T20:54:03.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":113.21,"value":113210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":435973,"source":{"system":"sec-edgar","filing":"0001765581-25-000049","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000049/edgardoc.xml","form_type":"4"}},{"id":1092072,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-07-03T18:56:04.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":110,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":436973,"source":{"system":"sec-edgar","filing":"0001765581-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000046/edgardoc.xml","form_type":"4"}},{"id":1092071,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-07-03T18:56:04.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":105.26,"value":52630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":437473,"source":{"system":"sec-edgar","filing":"0001765581-25-000046","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000046/edgardoc.xml","form_type":"4"}},{"id":1122635,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-06-04T20:50:28.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":500,"price":110,"value":55000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":437973,"source":{"system":"sec-edgar","filing":"0001765581-25-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000044/edgardoc.xml","form_type":"4"}},{"id":1122634,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-06-04T20:50:28.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":500,"price":107.9,"value":53950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025."}],"balance_after":438473,"source":{"system":"sec-edgar","filing":"0001765581-25-000044","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000044/edgardoc.xml","form_type":"4"}},{"id":1134990,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:11:07.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":92158,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":92158},"source":{"system":"sec-edgar","filing":"0001962918-25-000066","document":"wk-form4_1748031058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000196291825000066/wk-form4_1748031058.xml","form_type":"4"}},{"id":1134989,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:11:07.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23243,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/36 of the shares subject to the option vested on June 4, 2023, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":23243},"source":{"system":"sec-edgar","filing":"0001962918-25-000066","document":"wk-form4_1748031058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000196291825000066/wk-form4_1748031058.xml","form_type":"4"}},{"id":1134988,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:11:07.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":183434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the shares subject to the option vested on April 7, 2022, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":0,"derivative":{"exercise_price":4.0426,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":183434},"source":{"system":"sec-edgar","filing":"0001962918-25-000066","document":"wk-form4_1748031058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000196291825000066/wk-form4_1748031058.xml","form_type":"4"}},{"id":1158889,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T23:00:39.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":500,"price":120,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":438807,"source":{"system":"sec-edgar","filing":"0001765581-25-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000039/edgardoc.xml","form_type":"4"}},{"id":1158888,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-05-05T23:00:39.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":116.35,"value":116350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":439307,"source":{"system":"sec-edgar","filing":"0001765581-25-000039","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000039/edgardoc.xml","form_type":"4"}},{"id":1179133,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-04-03T21:32:10.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":123.75,"value":185625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":440307,"source":{"system":"sec-edgar","filing":"0001765581-25-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000037/edgardoc.xml","form_type":"4"}},{"id":1217096,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-07T23:43:29.000Z","date":"2025-03-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22251,"price":138.95,"value":3091776.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":441807,"source":{"system":"sec-edgar","filing":"0001765581-25-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000024/edgardoc.xml","form_type":"4"}},{"id":1235478,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:13:20.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":144.25,"value":937625.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":464058,"source":{"system":"sec-edgar","filing":"0001765581-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000006/edgardoc.xml","form_type":"4"}},{"id":1235477,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:13:20.000Z","date":"2025-02-27","kind":"grant","planned":true,"acquired":true,"shares":30814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026."}],"balance_after":470558,"source":{"system":"sec-edgar","filing":"0001765581-25-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000006/edgardoc.xml","form_type":"4"}},{"id":1281644,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-02-05T22:41:34.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":122.31,"value":183465.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":439744,"source":{"system":"sec-edgar","filing":"0001805688-25-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000015/edgardoc.xml","form_type":"4"}},{"id":1297364,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:55:27.000Z","date":"2025-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":13840,"price":122.62,"value":1697060.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":441244,"source":{"system":"sec-edgar","filing":"0001805688-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000011/edgardoc.xml","form_type":"4"}},{"id":1297363,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:55:27.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":29559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified."}],"balance_after":455084,"source":{"system":"sec-edgar","filing":"0001805688-25-000011","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000180568825000011/edgardoc.xml","form_type":"4"}},{"id":1310077,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2025-01-06T21:22:37.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":123.43,"value":185145.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":425525,"source":{"system":"sec-edgar","filing":"0001765581-25-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558125000002/edgardoc.xml","form_type":"4"}},{"id":1342722,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-12-04T22:24:08.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":121.17,"value":242340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 49 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024."}],"balance_after":427025,"source":{"system":"sec-edgar","filing":"0001765581-24-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000092/edgardoc.xml","form_type":"4"}},{"id":1375148,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-11-05T22:00:57.000Z","date":"2024-11-01","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":110.84,"value":110840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 167 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":428976,"source":{"system":"sec-edgar","filing":"0001765581-24-000086","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000086/edgardoc.xml","form_type":"4"}},{"id":1483190,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-06-11T23:17:22.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":92158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":92158,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":92158},"source":{"system":"sec-edgar","filing":"0001962918-24-000095","document":"wk-form4_1718147835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000196291824000095/wk-form4_1718147835.xml","form_type":"4"}},{"id":1588891,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-03-08T02:44:56.000Z","date":"2024-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":22436,"price":117.53,"value":2636903.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":429809,"source":{"system":"sec-edgar","filing":"0001765581-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000028/edgardoc.xml","form_type":"4"}},{"id":1595010,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-03-06T00:34:26.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":50187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":452245,"source":{"system":"sec-edgar","filing":"0001765581-24-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558124000013/edgardoc.xml","form_type":"4"}},{"id":1675059,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:21:32.000Z","date":"2024-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":12245,"price":119.13,"value":1458746.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":402058,"source":{"system":"sec-edgar","filing":"0001784606-24-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000004/edgardoc.xml","form_type":"4"}},{"id":1675058,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:21:32.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":26545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 137 ordinary shares and 37 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 31, 2023 and November 30, 2023, respectively."}],"balance_after":414303,"source":{"system":"sec-edgar","filing":"0001784606-24-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000178460624000004/edgardoc.xml","form_type":"4"}},{"id":1896532,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:04:30.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":23243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/36 of the shares subject to the option vest on June 4, 2023, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":23243,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":23243},"source":{"system":"sec-edgar","filing":"0001209191-23-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000120919123028876/doc4.xml","form_type":"4"}},{"id":1896531,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:04:30.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":23243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/36 of the shares subject to the option vest on June 4, 2023, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Class A Common Stock","underlying_shares":23243},"source":{"system":"sec-edgar","filing":"0001209191-23-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000120919123028876/doc4.xml","form_type":"4"}},{"id":1896530,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:04:30.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":true,"shares":183434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option vested on April 7, 2022, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":183434,"derivative":{"exercise_price":4.0426,"expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":183434},"source":{"system":"sec-edgar","filing":"0001209191-23-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000120919123028876/doc4.xml","form_type":"4"}},{"id":1896529,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-12T01:04:30.000Z","date":"2023-05-09","kind":"other","planned":false,"acquired":false,"shares":183434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the shares subject to the option vested on April 7, 2022, and 1/48 of the shares subject to the option vests in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share of Class A Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":0,"derivative":{"exercise_price":4.0426,"expiration_date":"2032-03-07","underlying":"Class A Common Stock","underlying_shares":183434},"source":{"system":"sec-edgar","filing":"0001209191-23-028876","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000120919123028876/doc4.xml","form_type":"4"}},{"id":1904192,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-05-05T00:13:58.000Z","date":"2023-05-04","kind":"grant","planned":false,"acquired":true,"shares":23243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36 of the shares subject to the option vest on June 4, 2023, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"Each share of Class A Common Stock shall be reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock."}],"balance_after":23243,"derivative":{"exercise_price":18,"expiration_date":"2033-05-03","underlying":"Class A Common","underlying_shares":23243},"source":{"system":"sec-edgar","filing":"0001209191-23-027526","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1193210/000120919123027526/doc4.xml","form_type":"4"}},{"id":1965446,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:44:45.000Z","date":"2023-03-05","kind":"tax_withholding","acquired":false,"shares":21882,"price":142.78,"value":3124311.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":387584,"source":{"system":"sec-edgar","filing":"0001765581-23-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000015/edgardoc.xml","form_type":"4"}},{"id":1965445,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:44:45.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":42388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":409466,"source":{"system":"sec-edgar","filing":"0001765581-23-000015","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000015/edgardoc.xml","form_type":"4"}},{"id":2032578,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2023-02-03T23:45:35.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":1000,"price":155.79,"value":155790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":367078,"source":{"system":"sec-edgar","filing":"0001765581-23-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000006/edgardoc.xml","form_type":"4"}},{"id":2062107,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:41:50.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":2000,"price":160,"value":320000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":368078,"source":{"system":"sec-edgar","filing":"0001765581-23-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000002/edgardoc.xml","form_type":"4"}},{"id":2062106,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:41:50.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":1000,"price":159.59,"value":159590.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":370078,"source":{"system":"sec-edgar","filing":"0001765581-23-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000002/edgardoc.xml","form_type":"4"}},{"id":2095820,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-12-05T22:03:56.000Z","date":"2022-12-01","kind":"sale","acquired":false,"shares":1000,"price":157,"value":157000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 50 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2022."}],"balance_after":371078,"source":{"system":"sec-edgar","filing":"0001765581-22-000128","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000128/edgardoc.xml","form_type":"4"}},{"id":2117658,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-11-14T22:39:35.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":2000,"price":150,"value":300000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":372028,"source":{"system":"sec-edgar","filing":"0001765581-22-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000118/edgardoc.xml","form_type":"4"}},{"id":2142057,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-10-05T22:43:30.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":62905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017."}],"balance_after":0,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":62905},"source":{"system":"sec-edgar","filing":"0001765581-22-000116","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000116/edgardoc.xml","form_type":"4"}},{"id":2142056,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-10-05T22:43:30.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":7748,"price":135.8045,"value":1052213.266,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.57 to $136.30. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":374028,"source":{"system":"sec-edgar","filing":"0001765581-22-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000116/edgardoc.xml","form_type":"4"}},{"id":2142055,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-10-05T22:43:30.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":23646,"price":135.1766,"value":3196385.8836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $134.57 to $135.56. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":381776,"source":{"system":"sec-edgar","filing":"0001765581-22-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000116/edgardoc.xml","form_type":"4"}},{"id":2142054,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-10-05T22:43:30.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":13791,"price":134.0227,"value":1848307.0557,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $133.56 to $134.54. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":405422,"source":{"system":"sec-edgar","filing":"0001765581-22-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000116/edgardoc.xml","form_type":"4"}},{"id":2142053,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-10-05T22:43:30.000Z","date":"2022-10-03","kind":"exercise","acquired":true,"shares":62905,"price":59.13,"value":3719572.65,"ownership":{"direct":true},"balance_after":419213,"source":{"system":"sec-edgar","filing":"0001765581-22-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000116/edgardoc.xml","form_type":"4"}},{"id":2162986,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017."}],"balance_after":62905,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162985,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":542,"price":155.22,"value":84129.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $155.095 to $155.74. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":356308,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162984,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":474,"price":154.31,"value":73142.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.93 to $154.66. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":356850,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162983,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":1170,"price":153.13,"value":179162.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.87 to $153.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":357324,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162982,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":4517,"price":152.41,"value":688435.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.87 to $152.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":358494,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162981,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":9700,"price":59.13,"value":573561.0,"ownership":{"direct":true},"balance_after":363011,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2162980,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-09-08T20:55:04.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":1000,"price":155.1,"value":155100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":353311,"source":{"system":"sec-edgar","filing":"0001765581-22-000111","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000111/edgardoc.xml","form_type":"4"}},{"id":2195452,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":68,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017."}],"balance_after":72605,"derivative":{"exercise_price":59.13,"expiration_date":"2023-03-04","underlying":"Ordinary Shares","underlying_shares":68},"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195451,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":9632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":9632},"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195450,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":1000,"price":154.94,"value":154940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":354311,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195449,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":1100,"price":155.268,"value":170794.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $155.015 to $155.66. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":355311,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195448,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":2601,"price":154.5015,"value":401858.4015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $154.01 to $154.95. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":356411,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195447,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":2600,"price":153.4816,"value":399052.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.01 to $153.935. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":359012,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195446,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":68,"price":59.13,"value":4020.84,"ownership":{"direct":true},"balance_after":361612,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2195445,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-08-03T20:58:22.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":9632,"price":46.83,"value":451066.56,"ownership":{"direct":true},"balance_after":361544,"source":{"system":"sec-edgar","filing":"0001765581-22-000073","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000073/edgardoc.xml","form_type":"4"}},{"id":2210646,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016."}],"balance_after":9632,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2210645,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":1500,"price":160,"value":240000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":351912,"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2210644,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":1000,"price":156.95,"value":156950.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":353412,"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2210643,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":436,"price":157.1306,"value":68508.9416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $157.05 to $157.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":354412,"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2210642,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":5839,"price":156.6513,"value":914686.9407,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to pay option price and to satisfy tax obligations arising from the exercise of stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $156.05 to $157.03. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":354848,"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2210641,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Ordinary Shares","published_at":"2022-07-07T21:11:50.000Z","date":"2022-07-05","kind":"exercise","acquired":true,"shares":9700,"price":46.83,"value":454251.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":360687,"source":{"system":"sec-edgar","filing":"0001765581-22-000067","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000067/edgardoc.xml","form_type":"4"}},{"id":2244178,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":819,"kind":"person","name":"COZADD BRUCE C","position":1,"cik":"0001193210","reported_name":"COZADD BRUCE C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-03T19:04:21.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":9700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This Non-qualified stock option is part of an option granted on August 9, 2012. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of August 9, 2016."}],"balance_after":19332,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":9700},"source":{"system":"sec-edgar","filing":"0001765581-22-000053","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000053/edgardoc.xml","form_type":"4"}}],"next_cursor":"2022-06-03T19:04:21.000000Z,2244178"}